Metabolism 'rewiring' leads to aggressive lung cancers
2/24/2016
Scientists have discovered that lung cancers with extra copies of a cancer causing gene-defect 'rewire' their energy supply, helping them to survive and making them more likely to spread.
The key to mass-producing nanomaterials
2/24/2016
Researchers create a system that can scale-up production of the smallest -- but among the most useful -- materials of this century.
Genetically engineered immune cell therapy found to boost survival in mice with brain tumors
2/24/2016
For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy.
Eli Lilly and Company has announced that the European Commission has granted a marketing authorisation for necitumumab (PortrazzaTM), for use in combination with gemcitabine and cisplatin...
Eli Lilly and Company has announced that the European Commission has granted a marketing authorisation for necitumumab (PortrazzaTM), for use in combination with gemcitabine and cisplatin...
Cancer patients who report significant symptoms of depression before undergoing a complex abdominal surgery are at increased risk of postoperative complications and unplanned hospital readmissions...
Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company discovering and developing peptide-based cancer therapeutics, has announced top-line results from its Phase 1...
New therapeutic pathway may keep cancer cells turned 'off'
2/24/2016
Tel Aviv University researchers offer proof of concept for new nanomedicine designed to inhibit tumor growth by keeping cancer dormant.
Two forms of radiosurgery for brain metastases are equally effective
2/24/2016
While two advanced radiosurgery approaches -- Gamma Knife and RapidArc® -- offer different strengths, they are equally effective at eradicating cancer in the brain, say researchers at Sidney...
HPV rates fallen sharply in young women since vaccine introduced
2/24/2016
New study shows that since the HPV vaccination campaign started in 2006, rates of the four targeted strains of the cancer-causing virus have fallen sharply in young American women.